Medpace

On World Juvenile Arthritis Day, join Medpace in raising awareness for the 1 in 1,000 children living with juvenile arthritis. The rheumatology space is ever evolving and there is a large unmet medical need for new and effective therapies for rheumatic diseases. Medpace is committed to advancing clinical development in order to improve the lives of those impacted by these diseases. Our cross-therapeutic experience using a variety of treatment classes is key for managing complex #pediatric #rheumatology trials. Contact our experts to learn more: https://lnkd.in/gAxJq6Vu

In our latest case study, Medpace #neurodegenerative experts share strategies for overcoming key challenges of Huntington's disease studies, including complex patient logistics, subject retention, study blinding requirements, protocol amendments, and more. Download the case study to explore effective approaches that resulted in high patient retention, quality data, and enhanced satisfaction for both patients and sites: https://lnkd.in/gAJgP5-n

Today is #WorldKidneyDay, a time to raise awareness of the importance of our kidneys and to reduce the impact of chronic kidney disease, which affects approximately 850 million people worldwide. At Medpace, we recognize the urgent need for new therapies that are universally accessible to all patients, and we remain committed to accelerating the safe and effective development of #nephrology therapeutics. Hear from Sr. Vice President, Ajay Srivastava, MD, FASN on how Medpace is working to reduce the impact of kidney disease through our cross-functional integration. https://lnkd.in/eqZPJG5U

Medpace's #oncology experts recently led a global First-In-Human (FIH) study of an Antibody-Drug Conjugate (ADC) for advanced solid tumors, ensuring patient safety while managing the risk of ocular toxicities from the ADC's payload. Through strategic safety measures, including enabling proactive site training and safety oversight, we ensured patient safety while advancing this promising therapy. Discover how our team kept the ADC development on track while prioritizing patient safety—read the full case study now: https://lnkd.in/g-Fy-iqh #PatientSafetyAwarnessWeek

The cardiology world will come together for #ACC25 in Chicago, IL, March 29-31 to share the latest updates in the field with a focus on transforming cardiovascular care for all. As a leader in cardiovascular clinical development, Medpace brings unparalleled expertise to accelerate your next breakthrough. Our #cardiovascular experts will be available to learn about your clinical development plans and share how our full-service model can lead to success. Request a meeting with our on-site team: https://lnkd.in/g4mfsySc

"In a way, [resumes are] a first impression," says Medpace Recruiter Kay Butler. Graduation will be here in no time, so brush up on resume tips! Revisit our blog with talent acquisition specialist Kay Butler as she gives insight into how you can optimize your resume for your job seeking journey. Read more: https://bit.ly/3DmC4Uf #WorkAtMedpace

This #PatientSafetyAwarenessWeek, we're highlighting how Medpace partnered with an emerging biotech to navigate the complexities of early-phase clinical development—while keeping patient safety at the forefront. Our latest case study showcases how the Medpace Phase I Unit guided a biopharmaceutical company through a complex Single Ascending Dose (SAD)/Multiple Ascending Dose (MAD) trial, meeting both safety and scientific objectives. By integrating scientific, medical, and operational expertise, Medpace helps biotech bring innovative therapies to market—safely and effectively. Read the full case study to learn more: https://lnkd.in/g4HfvXdF

On International Women's Day, we recognize the pressing need for innovation in #WomensHealth clinical research. At Medpace, we partner with leading biopharmaceutical companies to advance breakthroughs in women’s health indications. Our experts apply deep knowledge of disease processes and pathophysiology, novel trial designs, and patient-centered strategies to accelerate development and improve outcomes for women worldwide. Explore how our full-service model and therapeutically aligned leadership team can help bring your women's health therapies to market: https://lnkd.in/gXDRwUj2 #InternationalWomensDay #IWD2025 #WomensHealthCRO 

Medpace is delighted to announce that Centre Eugène Marquis has become part of our Flagship Site Program! Thank you to all the teams for their hard work, excellence and commitment to deliver high quality data, contributing to accelerating the global development of safe and effective medical therapeutics. Learn more about how Medpace optimizes site global selection and patient engagement for our Sponsors by visiting our website: https://lnkd.in/gdtmrS82

Medpace is growing! We have expanded our operations by hiring our first colleagues in four new countries: Norway, Estonia, Latvia, and Lithuania. We are excited to continue developing our global reach to bring life saving drugs and medical devices to people around the world. Want to join our global team? Apply today to make a difference tomorrow: https://bit.ly/3YWjlHH #WorkAtMedpace